Estrogen/elcometrine contraceptive sprays - Acrux

Drug Profile

Estrogen/elcometrine contraceptive sprays - Acrux

Alternative Names: Combination contraceptive sprays - Acrux; Duomist; Estrogen/Nestorone® contraceptive sprays; Estrogen/progestogen contraceptive sprays; Estrogens/elcometrine; Ethinylestradiol/elcometrine

Latest Information Update: 23 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Acrux
  • Class Hormonal contraceptives; Hormonal replacements
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Pregnancy

Most Recent Events

  • 12 Jun 2014 Discontinued - Phase-I for Contraception/Pregnancy (Prevention) in Australia (Transdermal)
  • 29 May 2014 KV Pharmaceutical is now called Lumara Health
  • 14 Aug 2008 Phase I development is ongoing in Australia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top